– Statement
SVB Leerink Maintains Market Perform on 4D Molecular Therapeutics, Lowers Price Target to $14
SVB Leerink analyst Mani Foroohar maintains 4D Molecular Therapeutics (NASDAQ:FDMT) with a Market Perform and lowers the price target from $15 to $14.